Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

AI Stocks to Watch: 3 Names for Your Short List

There are different ways to invest in artificial intelligence; here are three AI stocks to watch that give you exposure to this super cycle.

3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall

Even with higher for longer interest rates, drug discovery moves on. That’s why it’s still a good time to look for biotech stocks to buy.

3 Airline Stocks That Should Be on Every Investor’s Radar This Fall

But long-term investors may be rewarded for taking a calculated investment in some of the leading names in the sector. 

The 7 Most Undervalued Retirement Stocks to Buy in a September 2023

Finding undervalued retirement stocks can help you build a solid nest egg for what will likely be a longer retirement

The 3 Most Undervalued Pharma Stocks to Buy in September 2023

Investing in pharmaceutical industry always carries risk, but several pharma stocks have an attractive risk/reward valuation right now.